Effects of U50488 and bremazocine on [Ca2+](i) and cAMP in naive and tolerant rat ventricular myocytes: Evidence of kappa opioid receptor multiplicity in the heart

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 2, 1999, Pages 355-362

  Zhang, Wei Min ^a   Wu, Song ^a   Yu, Xiao Chun ^a   Wang, Hong Xin ^a   Bian, Jin Song ^a   Wong, Tak Ming ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cAMP; Electrically stimulated Ca2+ (i) transient; Tolerance; Ventricular myocytes; 1 receptor; 2 receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BREMAZOCINE; CALCIUM ION; CYCLIC AMP; FORSKOLIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; QUADAZOCINE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART MUSCLE CELL; HEART VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033083472     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.9998     Document Type: Article

References (47)

1. Attali B, Gouarderes C, Mazarguil H, Audigier Y, Cros J, 1982a. Differential interaction of opiates to multiple "kappa" binding sites in the guinea-pig lumbo-sacral spinal cord. Life Sci 31: 1371-1375.
2. Attali B, Gouarderes C, Mazarguil H, Audigier Y, Cros J, 1982b. Evidence for multiple "kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord. Neuropeptides 3: 53-64.
3. Barrallo A, Gonzáles-Sarmiento R, Santos MV, Rodrígues RE, 1995. RT-PCR detection of opioid receptor mRNA in different tissues. Analgesia 1(4-6): 272-277.
4. Boachie-Ansah G, Sitsapesan R, Kane KA, Parratt JR, 1989. The antiarrhythmic and cardiac electrophysiological effects of buprenorphine. Br J Pharmacol 97: 801-808.
5. Butelman ER, Negus SS, Ai Y, De-Costa BR, Woods JH, 1993. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267: 1269-1276.
6. 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J Neurosci 14: 5580-5589.
7. 3 subtype. J Pharmacol Exp Ther 251: 461-468.
8. Dong H, Sheng JZ, Lee CM, Wong TM, 1993. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline. Br J Pharmacol 109: 113-119.
9. 2+ transients. Circ Res 69: 1369-1379.
10. Hohl CM, Wetze S, Fertel RH, Wimsatt DK, Brierley GP, Altschuld RA, 1989. Hyperthyroid adult rat cardiomyocytes. I. Nucleotide content, β- and α-adrenoreceptors, and camp production. Am J Physiol 257: C948-C956.
11. Koran P, De-Costa BR, Rice KC, Porreca F, 1991. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: Evidence of kappa opioid receptor multiplicity in mice. J Pharmacol Exp Ther 257: 1154-1161.
12. Koran P, De-Costa BR, Rice KC, Haaseth RC, Hruby VJ, Porreca F, 1993a. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: Further functional evidence of opioid κ receptor multiplicity in the mouse. J Pharmacol Exp Ther 266: 926-933.
13. Horan PJ, Porreca F, 1993b. Lack of cross-tolerance between U69,593 and bremazocine suggests κ-opioid receptor multiplicity in mice. Eur J Pharmacol 239: 93-98.
14. Horan P, Taylaor J, Yamamura HI, Porreca F, 1992. Extremely long-lasting antagonistic actions of norbinaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260: 1237-1243.
15. 3H]U69593 binding sites in the rat heart. J Mol Cell Cardiol 27: 1507-1511.
16. Krumins SA, Faden AI, Feuerstein G, 1985. Opiate binding in rat hearts: Modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun 127: 120-128.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
18. Mcintosh M, Kane K, Parratt J, 1992. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia. Eur J Pharmacol 210: 37-44.
19. Nock B, Giordano AL, Cicero TJ, O'Connor LH, 1990. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: The U-69, 593-insensitive site appears to be the beta endorphin-specific epsilon receptor. J Pharmacol Exp Ther 254: 412-419.
20. 3H]ethylketocyclazocine. Life Sci 42: 2403-2412.
21. Paul D, Levison JA, Howard DH, Pick CG, Hahn EF, Pasternak GW, 1990. Naloxone benzoylhydrazone (NalBzoH) analgesia. J Pharmacol Exp Ther 255: 769-774.
22. Pfeiffer A, Pasi A, Mehraein P, Herz A, 1981. A subclassification of κ-sites in human brain by use of dynorphin 1-17. Neuropeptides 2: 89-97.
23. Portoghese PS, Lipkowski AW, Takemori AE, 1987. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 40: 1287-1292.
24. Rocha-Singh KJ, Hines DK, Honbo NY, Karliner JS, 1991. Concanavalin A amplifies both β-adrenergic and muscarinic cholinergic receptor-adenylate cyclase-linked pathways in cardiac myocytes. J Clin Invest 88: 760-766.
25. Rothman RB, Bykov V, De Costa BR, Jacobson AE, Rice KC, Brady LS, 1990. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides 11: 311-331.
26. 2+ elevations evoked by κ-opioid receptor in rat myocytes. Eur J Pharmacol 307: 323-329.
27. i in myocytes. Am J Physiol (Cell Physiol 41) 272: C560-C564.
28. Sitsapesan R, Parratt JR, 1989. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br J Pharmacol 97: 795-800.
29. 3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol 23: 1297-1302.
30. Takemori AE, Ho BY, Naeseth JS, Portoghese PS, 1988a. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246: 255-258.
31. Takemori AE, Schwartz MM, Portoghese PS, 1988b. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats. J Exp Pharmacol Ther 247: 971-974.
32. 3H] batrachotoxinin benzoate binding sites on rat cardiac myocytes. J Biol Chem 266: 10300-10304.
33. 2 receptors by a computerized model-fitting technique. Mol Pharmacol 37: 694-703.
34. Tortella PC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS, Holaday JW, 1989. Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci 44: 661-665.
35. Tseng LF, Collins KA, 1991. Involvement of the epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse. J Pharmacol Exp Ther 259: 330-336.
36. 2 opioid receptors in rat and guinea pig brain. Brain Res 562: 57-65.
37. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C, 1989. Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and isoproterenol. Biochim Biophys Acta 987: 69-74.
38. 2+ release from an intracellular pool in myocytes and neurons. Circ Res 70: 66-81.
39. Weihe E, Mcknight AT, Corbett AD, Kosterlitz HW, 1985. Proenkephalin- and prodynorphin-derived opioid peptides in guinea-pig heart. Neuropeptides 5: 453-456.
40. Wittert G, Hope P, Pyle D, 1996. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 218: 877-881.
41. Wong TM, Lee AYS, Tai KK, 1990. Effects of drugs interacting with opioid receptors during normal perfusion or ischaemia and reperfusion in the isolated rat heart - An attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22: 1167-1175.
42. Xia Q, Sheng JZ, Tai KK, Wong TM, 1994. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts. J Pharmacol Exp Ther 268: 930-934.
43. Yamada K, Yoshida S, Shimada Y, 1991. Atrial natriuretic polypeptide secretion via selective activation of κ-opioid receptor: Role of dynorphin. Am J Physiol 261: E293-E297.
44. Zhang WM, Jin WQ, Wong TM, 1996. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 28: 1547-1554.
45. 3H]-U69 593 binding and the cardiac effects of U50,488H by calcium channel blockers in the rat heart. Br J Pharmacol 120: 827-832.
46. 2+ pathway in the cardiac κ-opioid receptor. Am J Physiol 274 (Cell Physiol 43): C82-C87.
47. 2 opioid receptors. P Roc Natl Acad Sci USA 85: 4061-4065.